PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
10.15%
Some net income increase while MCHP is negative at -40.45%. John Neff would see a short-term edge over the struggling competitor.
2.49%
Some D&A expansion while MCHP is negative at -2.39%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
-112.50%
Negative yoy deferred tax while MCHP stands at 102.63%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
13.11%
SBC growth well above MCHP's 17.22%. Michael Burry would flag major dilution risk vs. competitor’s approach.
67.77%
Slight usage while MCHP is negative at -161.22%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
95.88%
AR growth while MCHP is negative at -123.68%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
-38.46%
Both reduce yoy inventory, with MCHP at -114.06%. Martin Whitman would find a widespread caution or cyclical demand drop in the niche.
-124.64%
Negative yoy AP while MCHP is 125.75%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
52.00%
Some yoy usage while MCHP is negative at -217.13%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-2750.00%
Negative yoy while MCHP is 19.89%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
14.65%
Some CFO growth while MCHP is negative at -9.17%. John Neff would note a short-term liquidity lead over the competitor.
-25.32%
Negative yoy CapEx while MCHP is 33.68%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
29.83%
Purchases growth of 29.83% while MCHP is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
22.75%
Below 50% of MCHP's 100.00%. Michael Burry would see minimal near-term inflows vs. competitor’s liquidation approach.
-1878.95%
Both yoy lines negative, with MCHP at -146.75%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
111.45%
We have mild expansions while MCHP is negative at -146.75%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
100.00%
Debt repayment above 1.5x MCHP's 66.15%, indicating stronger deleveraging. David Dodd would verify if expansions are not neglected.
-72.45%
Negative yoy issuance while MCHP is 69.09%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-46.00%
We cut yoy buybacks while MCHP is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.